Additionally, CD34 functions as a stemness marker for acute myelogenous leukemia, which is a hematological malignant tumor with abnormal proliferation of bone marrow hematopoietic cells and is the most common acute leukemia in adults [45,46]. Here, CD34 is linked to acute leukemia.